1
Open-label Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD and Mood Symptoms
Condition(s):Attention-Deficit/Hyperactivity DisorderLast Updated:March 25, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Attention-Deficit/Hyperactivity DisorderLast Updated:March 25, 2024Recruiting
Condition(s):Attention-Deficit/Hyperactivity DisorderLast Updated:February 13, 2024Completed
Condition(s):Pregnant Women; Psychotropic DrugsLast Updated:November 13, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.